Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ·Healthcare·Biotechnology
$12.56
-6.58%
Mkt Cap $1.03B
Analyst Ratings
No recent rating data.
Price Target (13 analysts)
$35.00
Range $30.00 – $40.00
Implied Upside
+178.8%
Consensus $35.00 vs current $12.56
NASDAQ·Healthcare·Biotechnology
$12.56
-6.58%
Mkt Cap $1.03B
No recent rating data.
Price Target (13 analysts)
$35.00
Range $30.00 – $40.00
+178.8%
Consensus $35.00 vs current $12.56